Moderna

Overview

Moderna set out to change the world and make mRNA medicines a reality for humanity. The company was founded in 2010 and has headquarters in Massachusetts, US. The company generated revenue of $19.3 billion in 2022 with an employee size of 3,900. Messenger RNA is not a new technology, but the company is discovering new ways to use it to treat and prevent illnesses and diseases. Since its founding in 2010, the company has worked to build the industry's leading mRNA technology platform. Moderna provides real-time instructions to make the proteins necessary to drive all aspects of biology, including human health and disease. The company offers medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed, and manufactured. The company has partners such as AstraZeneca, Merck, Vertex, BARDA, DARPA, and more.

Get access to comprehensive company profiles and unlock new business opportunities.

We research company profiles for all industries.
We provide up-to-date reports to save your time.
Our report provides the company’s position, performance and strategic analysis.
Gain a competitive edge and increase your growth.

Life time access

$119 $149

BUY NOW

Quick Facts

Company Name	Moderna
Industry	Biotechnology Research
HQ Address	Massachusetts, US
Revenue	$19.3 billion
Employee Size	3900
Company Type	Public
Fiscal Year-End	December 31st
Website	www.modernatx.com
Subsidiaries	ModernaTX, Inc., Moderna Therapeutics Sweden AB, Brizo Ltd., and Moderna Securities Inc.
Locations	17 Across North America, Europe, & Asia-Pacific
Competitors	RaNA Therapeutics, Sarepta Therapeutics, Alnylam Pharmaceuticals and Regulus Therapeutics
Recognition & Awards	Great Place to Work, Forbes Best Employers for Women, Axios Harris Poll 100 Reputation Ranking, and More.